These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1358653)

  • 1. Suppression by dynorphin A-(1-13) of the expression of opiate withdrawal and tolerance in mice.
    Takemori AE; Loh HH; Lee NM
    Eur J Pharmacol; 1992 Oct; 221(2-3):223-6. PubMed ID: 1358653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynorphin A modulates acute and chronic opioid effects.
    Hooke LP; He L; Lee NM
    J Pharmacol Exp Ther; 1995 Apr; 273(1):292-7. PubMed ID: 7714779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression by dynorphin A and [des-Tyr1]dynorphin A peptides of the expression of opiate withdrawal and tolerance in morphine-dependent mice.
    Takemori AE; Loh HH; Lee NM
    J Pharmacol Exp Ther; 1993 Jul; 266(1):121-4. PubMed ID: 8101214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Des-Tyr1]dynorphin A-(2-17) has naloxone-insensitive antinociceptive effect in the writhing assay.
    Hooke LP; He L; Lee NM
    J Pharmacol Exp Ther; 1995 May; 273(2):802-7. PubMed ID: 7752083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynorphin A (2-17) attenuates the unconditioned but not the conditioned effects of opiate withdrawal in the rat.
    Shippenberg TS; Funada M; Schutz CG
    Psychopharmacology (Berl); 2000 Sep; 151(4):351-8. PubMed ID: 11026742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of acute morphine tolerance by corticotropin-releasing factor and dynorphin A in the mouse spinal cord.
    Song SH; Takemori AE
    Life Sci; 1992; 51(2):107-11. PubMed ID: 1352026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppressive effects by cysteine protease inhibitors on naloxone-precipitated withdrawal jumping in morphine-dependent mice.
    Tan-No K; Sato T; Shimoda M; Nakagawasai O; Niijima F; Kawamura S; Furuta S; Sato T; Satoh S; Silberring J; Terenius L; Tadano T
    Neuropeptides; 2010 Jun; 44(3):279-83. PubMed ID: 20189644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [D-Pro10]-dynorphin(1-11) is a kappa-selective opioid analgesic in mice.
    Gairin JE; Gout R; Meunier JC; Cros J
    J Pharmacol Exp Ther; 1988 Jun; 245(3):995-1001. PubMed ID: 2898527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Possible regulatory role of dynorphin-(1-13) on narcotic-induced changes in naloxone efficacy.
    Tulunay FC; Jen MF; Chang JK; Loh HH; Lee NM
    Eur J Pharmacol; 1981 Dec; 76(2-3):235-9. PubMed ID: 6277644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of morphine treatment and morphine withdrawal on the dynorphin and enkephalin systems in Sprague-Dawley rats.
    Nylander I; Vlaskovska M; Terenius L
    Psychopharmacology (Berl); 1995 Apr; 118(4):391-400. PubMed ID: 7568625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of quasi-morphine withdrawal syndrome in adenosine A2A receptor knockout mice.
    Bilbao A; Cippitelli A; Martín AB; Granado N; Ortiz O; Bezard E; Chen JF; Navarro M; Rodríguez de Fonseca F; Moratalla R
    Psychopharmacology (Berl); 2006 Apr; 185(2):160-8. PubMed ID: 16470403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynorphin-(1-13) restores the potency of morphine on the tolerant guinea pig ileum.
    Rezvani A; Way EL
    Eur J Pharmacol; 1984 Jul; 102(3-4):475-9. PubMed ID: 6149134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of naloxone and D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 and the protein kinase inhibitors H7 and H8 on acute morphine dependence and antinociceptive tolerance in mice.
    Bilsky EJ; Bernstein RN; Wang Z; Sadée W; Porreca F
    J Pharmacol Exp Ther; 1996 Apr; 277(1):484-90. PubMed ID: 8613958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between regulation of morphine-induced EEG effects and changes in naloxone sensitivity.
    Paquette NC; Young GA
    Eur J Pharmacol; 1991 Apr; 196(1):61-7. PubMed ID: 1678713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrathecally administered dynorphin-(1-17) modulates morphine-induced antinociception differently in morphine-naive and morphine-tolerant rats.
    Schmauss C; Herz A
    Eur J Pharmacol; 1987 Mar; 135(3):429-31. PubMed ID: 2884124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynorphin-(1-13): antinociceptive action and its effects on morphine analgesia and acute tolerance.
    Kishioka S; Morita N; Kitabata Y; Yamanishi T; Miyamoto Y; Ozaki M; Yamamoto H
    Jpn J Pharmacol; 1992 Nov; 60(3):197-207. PubMed ID: 1362787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynorphin A-(1-13) attenuates withdrawal in morphine-dependent rats: effect of route of administration.
    Green PG; Lee NM
    Eur J Pharmacol; 1988 Jan; 145(3):267-72. PubMed ID: 2895003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is withdrawal hyperalgesia in morphine-dependent mice a direct effect of a low concentration of the residual drug?
    Rubovitch V; Pick CG; Sarne Y
    Addict Biol; 2009 Sep; 14(4):438-46. PubMed ID: 19489750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physical dependence liability of dynorphin A analogs in rodents.
    Nakazawa T; Kaneko T; Yoshino H; Tachibana S; Goto M; Taki T; Yamatsu K
    Eur J Pharmacol; 1991 Aug; 201(2-3):185-9. PubMed ID: 1686757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynorphin (1-13): analgesia, hypothermia, cross-tolerance with morphine and beta-endorphin.
    Petrie EC; Tiffany ST; Baker TB; Dahl JL
    Peptides; 1982; 3(1):41-7. PubMed ID: 6281745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.